VBI Vaccines' Pan-Coronavirus Vaccine Candidate, VBI-2901, Induced Broad and Durable Protective Titers Against Variants of Concern Seite 1

27.09.2023 - VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced interim data from the Phase 1 clinical study of its multivalent pan-coronavirus ... Seite 1

Related Keywords

Canada ,Jeff Baxter ,Nasdaq ,Health Canada ,Vaccines Inc ,Vbi Vaccines Chart ,Bi Vaccines Kurs ,Bi Vaccines Aktie ,